Hildred Capital Partners

Hildred Capital Partners, LLC is a family investment firm located in New York City, established in 2014. The firm focuses on investing in a diverse array of securities, including both equity and debt, across various geographies and sectors, utilizing both active and passive management strategies. Hildred Capital Partners has a strong emphasis on private equity, particularly in situations where its principals can leverage their extensive management experience to enhance a company's performance. The firm’s management team possesses significant expertise in multiple fields, including healthcare, finance, real estate, and entertainment, which informs its investment decisions and strategies.

6 past transactions

AleraCare Holdings

Private Equity Round in 2023
AleraCare Holdings is a provider of both home and community-based healthcare and pharmacy services for high-need and medically complex populations.

Healthcare.com

Series C in 2022
HealthCare is an online health insurance company providing a data-driven shopping platform that helps American consumers enroll in individual health insurance and Medicare plans. HealthCare.com also develops and markets a portfolio of proprietary, direct-to-consumer health insurance, and supplemental insurance products under the name Pivot Health. Founded in 2014, the company is headquartered in New York City and is backed by PeopleFund and individual investors including current and former executives of Booking.com and Priceline. HealthCare.com is a 5-time honoree of the Inc. 5000 list of America’s fastest-growing companies.

Binx Health

Series E in 2021
Binx Health is committed to broadening convenient and equitable access to healthcare. The company's point-of-care diagnostic solutions empower its partners to overcome traditional barriers to care, extend their outreach, and deliver exceptional patient experiences. The binx io point-of-care molecular platform marks a significant milestone as the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males (urine) and females (vaginal swabs). It delivers results comparable to those of central lab performance, typically within about thirty minutes.

Crown Laboratories

Private Equity Round in 2019
Crown Laboratories is a fully integrated specialty pharmaceutical company offering Consumer Healthcare Products, Prescription Products, and Contract Development and manufacturing services.

Crown Laboratories

Private Equity Round in 2017
Crown Laboratories is a fully integrated specialty pharmaceutical company offering Consumer Healthcare Products, Prescription Products, and Contract Development and manufacturing services.

Pharmaceutics International

Venture Round in 2016
Pharmaceutics International operates as a science-driven contract development and manufacturing company. It offers scientific insight and depth of product knowledge to supply high-quality dosage forms that enhance the lives of patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.